Review: Potential of renin inhibition in cardiovascular disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (52)
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 • 8,612 citations
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 • 8,588 citations
Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
1991 • 8,296 citations
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 • 7,165 citations
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 • 5,812 citations
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 • 5,471 citations
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
2001 • 3,093 citations
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 • 3,065 citations
Global Burden of Cardiovascular Diseases
2001 • 2,932 citations
A Randomized Trial of Propranolol in Patients With Acute Myocardial Infarction
1982 • 1,286 citations
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial
2002 • 1,190 citations
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
1972 • 1,098 citations
The Renin-Angiotensin System
1978 • 969 citations
Niere und Kreislauf1
1898 • 761 citations
Tissue Angiotensin and Pathobiology of Vascular Disease
2001 • 750 citations
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
2002 • 545 citations
Angiotensin II Type 1 Receptor Blockers
2001 • 477 citations
Renal protective effect of enalapril in diabetic nephropathy.
1992 • 437 citations
Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease
1997 • 436 citations
A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR
1940 • 427 citations
Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)
2002 • 409 citations
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
1996 • 401 citations
Levels of angiotensin and molecular biology of the tissue renin angiotensin systems
1993 • 333 citations
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
2002 • 323 citations
Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin
2000 • 310 citations
The Renin-Angiotensin System
1974 • 307 citations
Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.
1995 • 303 citations
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
1996 • 294 citations
Metabolism of Angiotensin-(1–7) by Angiotensin-Converting Enzyme
1998 • 290 citations
Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor
1992 • 265 citations
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart
1997 • 246 citations
Angiotensin-(1–7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide
1997 • 245 citations
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension
1996 • 229 citations
Vasodepressor Actions of Angiotensin-(1–7) Unmasked During Combined Treatment With Lisinopril and Losartan
1998 • 228 citations
From the hope to the ontarget and the transcend studies: challenges in improving prognosis
2002 • 171 citations
Natriuretic action of angiotensin(1–7)
1994 • 155 citations
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.
1990 • 131 citations
Renin inhibition by substituted piperidines: A novel paradigm for the inhibition of monomeric aspartic proteinases?
1999 • 124 citations
Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure
2001 • 115 citations
Angiotensin (1???7) is an antagonist at the type 1 angiotensin II receptor
1994 • 108 citations
Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
1980 • 100 citations
Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
1994 • 78 citations
The Nature of Intracrine Peptide Hormone Action
1999 • 78 citations
Is there a future for renin inhibitors?
2001 • 69 citations
Renal Circulation and Blockade of the Renin-Angiotensin System
1995 • 62 citations
Effects of Blocking the Angiotensin II Receptor, Converting Enzyme, and Renin Activity on the Renal Hemodynamics of Normotensive Guinea Pigs
1993 • 45 citations
Effects of an Orally Active Renin Inhibitor, Ro 42-5892, in Patients With Essential Hypertension
1993 • 41 citations
Assessment of renin dependency of hypertension with a dipeptide renin inhibitor.
1990 • 41 citations
Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat
1991 • 39 citations
La sustancia hypertensora de la sangre del rinon isquemiado
1939 • 26 citations
Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension
1993 • 24 citations
Dose response antihypertensive efficacy of aliskiren (SPP 100), an orally active renin inhibitor
2002 • 9 citations